Market Cap (In AUD)
117.1 Million
Revenue (In AUD)
3.75 Million
Net Income (In AUD)
-35.97 Million
Avg. Volume
1 Million
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.41-0.83
- PE
- -2.36
- EPS
- -0.11
- Beta Value
- 1.342
- ISIN
- AU0000095416
- CUSIP
- -
- CIK
- -
- Shares
- 450419000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Andreas Fouras M.A.I.C.D., Ph.D.
- Employee Count
- -
- Website
- https://www.4dmedical.com
- Ipo Date
- 2020-08-07
- Details
- 4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
More Stocks
-
XWELXWELL, Inc.
XWEL
-
MANORAMAManorama Industries Limited
MANORAMA
-
TGRO
-
BONEH
-
SLX
-
MAURYMarui Group Co., Ltd.
MAURY
-
VSSL
-
002913